Finn Patrick John 4

What Happened

• Finn Patrick John, President and Chief Operating Officer of Twist Bioscience (TWST), sold 2,705 shares at $46.58 per share on 2026-02-03, generating proceeds of $125,988. The sale was a "sell-to-cover" tied to tax withholding for vested restricted stock units and not a discretionary open-market trade.

Key Details

• Transaction date: 2026-02-03; filing date: 2026-02-05 (Form 4 accession 0001214659-26-001237) — appears to be filed within the usual reporting window.
• Sale details: 2,705 shares @ $46.58; total proceeds $125,988.
• Reason/footnote: Footnote F1 states the sale was required to cover tax withholding on vested RSUs per the issuer’s equity plan (a mandated sell-to-cover, not a voluntary trade).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Transaction code: Reported as a sale (S) with a tax-withholding note (F1).

Context

• Sell-to-cover transactions are routine administrative sales to satisfy tax obligations when RSUs vest and generally do not reflect an insider’s discretionary view of the stock. For retail investors, purchases by insiders tend to be more indicative of bullish sentiment than mandatory tax-withholding sales.